All Updates

All Updates

icon
Filter
Partnerships
Certara collaborates with Cloudscientific to expedite drug research in China
AI Drug Discovery
May 10, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Yesterday
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Yesterday
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Yesterday
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Yesterday
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Yesterday
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Yesterday
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Yesterday
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Yesterday
AI Drug Discovery

AI Drug Discovery

May 10, 2024

Certara collaborates with Cloudscientific to expedite drug research in China

Partnerships

  • Pennsylvania-based pharmaceutical company Certara has entered a partnership with Cloudscientific, aimed at bringing AI-powered drug discovery tools to the Chinese healthcare research community.

  • The collaboration allows Certara's D360 discovery informatics platform and Certara. AI software is to be distributed in China via Cloudscientific to advance discovery research for small molecules and biological candidates. The D360 platform provides access to data and integrated scientific intelligence.

  • Certara specializes in providing software products and technology-enabled services, including AI-powered solutions to the pharmaceutical sector. The company's focus is on model-informed drug development, offering solutions that predict pharmacokinetics and pharmacodynamics through software services such as Simcyp Simulator, which predicts drug behavior within the human body, and Phoenix WinNonlin IVIV for in vitro-in vivo correlation (IVIVC) studies.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.